Table 2.
Reference | Tissue and cell source | Culture approach | Study highlight |
---|---|---|---|
Takai et al. [87], 2016 | HCC and hepatoblastoma | 3D culture with porous alginate scaffolds | 3D cultured immortalized HCC cells form glandular epithelial spheroids with increased stemness marker expression compared to cells in monolayer culture. |
Immortalized HCC cell lines | The 3D cultured HCC cells exhibit greater tumorigenicity and metastasis potential when engrafted in vivo. | ||
Broutier et al. [35], 2017 | HCC, CCC, cHCC-CCC | ICO culture | The study demonstrated the feasibility of generating tumoroids from all three major liver cancer subtypes using the ICO culture approach. |
Surgical resections | Tumoroid cultures retain histological architecture and the parental tumor’s mutational and gene expression profile. | ||
Nuciforo et al. [89], 2018 | HCC and CCC | ICO culture | The study demonstrates that the ICO culture method can also generate tumoroids from pre-surgical needle biopsy samples. |
Tumor Needle Biopsies | |||
Saltsman et al. [67], 2020 | Hepatoblastoma | ICO culture | A lack of human models has hindered hepatoblastoma research progress. This study further highlighted the broad utility of the ICO culture approach to generate liver cancer models. |
Surgical resections | |||
Li et al. [94], 2019 | HCC and CCC | ICO culture | The study explores the potential of capturing intra-tumor heterogeneity (ITH) across large HCC tumors using the ICO culture method. |
Multi-sections of a single large resected Tumor | Tumoroids generated from different sectors exhibit significant variation in drug resistance against a panel of 129 drugs. | ||
Artegiani et al. [96], 2019 | Healthy liver tissue | ICO culture | The study showed that oncogenic transformation of ICO using CRISPR-CAS9 mediated gene-editing enables modeling of cholangiocarcinoma development. |
Yang et al. [98], 2022 | Healthy fetal liver tissue | Hepatocyte organoid culture | The organoid culture approach enables the stable expansion of hepatocytes isolated from fetal liver tissue. Hippo-YAP activation induces malignant transformation of the fetal hepatocyte organoid into tumoroids resembling fetal hepatoblastoma. |
Sun et al. [100], 2019 | Human fibroblast | Trans-differentiated hepatic organoids | Overexpression of FOXA3, HNF1A, HNF4A, and SV40 large T antigen induces human fibroblast transdifferentiation to human-induced hepatic organoids (HiHeps). HiHeps can be employed to evaluate oncogenic effects and reveal mechanistic roles of known liver cancer driver genes. |
Cao et al. [107], 2019 | Tumor from mouse liver cancer models | ICO culture | Tumoroids derived from mouse liver cancer models can be expanded long-term and form tumors when engrafted. Tumors formed recapitulate the heterogeneity of liver cancer observed in cancer patients |
Cao et al. [95], 2020 | Genetically engineered mouse models (GEMMs) can be used in parallel for investigating the mechanism of cancer initiation and progression. |
HCC, hepatocellular carcinoma; CCC, cholangiocarcinoma; cHCC-CCC, combined hepatocellular cholangiocarcinoma; ICO, intrahepatic cholangiocyte organoids.